1

Role of MTH1 and MYH proteins

in genotoxic effects of radiation

Doctoral thesis in Molecular Genetics

Sara Shakeri Manesh

Centre for Radiation Protection Research

Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm

University, Sweden

Stockholm, 2015

2

Abstract

Humans are constantly exposed to different types of radiations. It has been suggested that low

dose and low dose rate of γ-radiation as well as ultra violet A (UVA) radiation induce oxidative

stress in cells that may promote mutations. The mechanisms behind radiation-induced oxidative

stress and its relation to genotoxicity and cancer induction are not well understood.

Understanding these mechanisms may provide valuable information for radiation protection

research and cancer prevention. In the majority of investigations, the DNA molecule has been

studied as the only target for stress induced mutations, however the results obtained in our group

point out that DNA bases in the cytoplasm (dNTP) could also be a significant mutagenic target of

oxidative stress. The nucleotide pool sanitization enzyme, MTH1, and the base excision repair

protein, MYH, are two of the key components of the repair pathway that can prevent mutations

arising from the formation of oxidative DNA base in the cell. In this thesis, we investigated the

role of MTH1 and MYH in genotoxicity of UVA and low dose rates of γ-radiation (paper I, II

and IV). The adaptive response to low dose rates of γ-radiation was investigated in paper III. The

human lymphoblastoid TK6 cell line was stably transfected with shRNA directed against MTH1

and/or MYH. The clonogenic cell survival assay was performed to investigate the cytotoxicity of

UVA and γ-radiation. Mutant frequency and chromosomal aberration assays were applied to

study mutagenicity of radiation. Our results indicated that acute exposure to UVA or γ-radiation

affects cell survival and also significantly increases the frequency of mutants above the

background. The frequency of mutants in MTH1 deficient cells was significantly higher than that

in wild types after exposure to UVA. Following exposure to γ-radiation, a higher frequency of

mutants was observed in cells lacking the expression of both MYH and MTH1, in comparison to

cells lacking either MYH or MTH1 or to wild type cells. No dose rate effect of γ-radiation for

mutations and stable type aberrations was observed in TK6 cells. An adaptive response to γ-

radiation was observed at the level of mutation in MCF-10A cells but not at the survival level. In

summary, our results suggest that MYH and MTH1 proteins cooperatively protect cells against

genotoxic effects of chronic oxidative stress induced by γ-radiation applied at low dose rates. We

also suggest that MTH1 protein protects cells from UVA-induced mutations. We speculate that

very low dose rates of γ-radiation may induce an in vitro adaptive response at the mutation level.

The important finding in this thesis implies that there is no dose rate effect for γ-radiation at the

level of mutations.

3

This thesis is based on the following papers:

1. Sara Shakeri Manesh, Marta Deperas-Kaminska, Asal Fotouhi, Traimate Sangsuwan,

Mats Harms-Ringdahl, Andrzej Wojcik, Siamak Haghdoost. Mutations and chromosomal

aberrations in hMTH1-transfected and non-transfected TK6 cells after exposure to low

dose rates of gamma radiation. Radiation and Environmental Biophysics 53:417–425,

2014

2. Sara Shakeri Manesh, Traimate Sangsuwan, Asal Fotouhi, Noushin S. Emami, Andrzej

Wojcik, Siamak Haghdoost. Cooperation of MTH1 and MYH proteins in response to

mutation induction by low dose rates of gamma radiation (submitted manuscript)

3. Sara Shakeri Manesh, Traimate Sangsuwan, Andrzej Wojcik, Siamak Haghdoost.

Adaptive response induced by different dose rates of gamma radiation in MCF-10A and

TK6 cells (manuscript)

4. Asal Fotouhi, Sara Skiöld, Sara Shakeri-Manesh, Siv Osterman-Golkar, Andrzej Wojcik,

Dag Jenssen, Mats Harms-Ringdahl, Siamak Haghdoost. Reduction of 8-oxodGTP in the

nucleotide pool by hMTH1 leads to reduction in mutations in the human lymphoblastoid

cell line TK6 exposed to UVA. Mutation Research 715:13-18, 2011

Publication not included in this thesis:

Li Dang, Halina Lisowska, Sara Shakeri Manesh, Alice Sollazzo, Marta Deperas-Kaminska,

Elina Staaf, Siamak Haghdoost, Karl Brehwens & Andrzej Wojcik. Radioprotective effect of

hypothermia on cells – a multiparametric approach to delineate the mechanisms.

International Journal of Radiation Biology 88: 507-514, 2012

4

Table of Contents

ABBREVIATIONS .......................................................................................................................... 5

INTRODUCTION ............................................................................................................................ 7

Radiation in human life ......................................................................................................................................... 7

Ionizing radiation .................................................................................................................................................. 7

Non-ionizing radiation ........................................................................................................................................ 11

Oxidative stress ................................................................................................................................................... 12

Oxidative stress biomarkers ................................................................................................................................ 14

DNA damage and repair ..................................................................................................................................... 15

Adaptive response................................................................................................................................................ 19

Bystander effect ................................................................................................................................................... 20

Radiation and epigenetics ................................................................................................................................... 20

AIM OF THE THESIS ................................................................................................................... 21

METHODOLOGY ......................................................................................................................... 21

RESULTS AND DISCUSSION .................................................................................................... 27

Paper I ................................................................................................................................................................. 27

Paper II ............................................................................................................................................................... 29

Paper III .............................................................................................................................................................. 31

Paper IV .............................................................................................................................................................. 33

CONCLUDING REMARKS ......................................................................................................... 35

ONGOING AND FUTURE STUDIES .......................................................................................... 36

ACKNOWLEDGMENT ................................................................................................................ 37

REFERENCES ............................................................................................................................... 39

5

Abbreviations

8-oxo-dA 8-oxo-2'-deoxyadenosine

8-oxo-dG 8-oxo-7, 8-dihydro-2'-deoxyguanosine

8-oxo-dGTP 8-oxo-7, 8-dihydro-2'-deoxyguanosine 5´-triphosphate

8-oxo-dGMP 8-oxo-7, 8-dihydro-2'-deoxyguanosine 5´-monophosphate

2-OH-dATP 2-hydroxy-2´-deoxyadenosine 5´-triphosphate

AP site Apurinic/apyrmidinic site

BEIR VII Biological effects of ionizing radiation VII

BER Base excision repair

CA Chromosomal aberrations

CPD Cyclobutyl pyrimidine dimers

DAPI 4',6-diamidino-2-phenylindole

DDREF Dose and dose rate effectiveness factor

DNMT1,3a and 3b DNA (cytosine-5)-methyltransferase 1,3 alpha and 3 beta

dNTP Deoxyribonucleoside triphosphate

DSB Double strand break

Gy Gray

FITC Fluorescein isothiocyanate

γ-radiation Gamma radiation

HMOX1 Heme oxygenase-1

hMTH1 Human MutT homolog protein 1

hMYH Human MutY homolog protein

hNUDT1 Human nudix (nucleoside diphosphate linked moiety X)-type motif 1

hOGG1 Human MutM homolog protein

HPRT Hypoxanthine phosphoribosyltransferase

H2O2 Hydrogen peroxide

HR Homologous recombination

ICRP International commission on radiological protection

IR Ionizing radiation

6

LET Linear energy transfer

LNT Linear non threshold

MCF-10A Human breast epithelial cell line

MnSOD Manganese superoxide dismutase

NADPH Nicotinamide adenine dinucleotide phosphate

NADH Nicotinamide adenine dinucleotide

NER Nucleotide excision repair

NHEJ Non homologous end joining

N-Tr Non-transfected

O2•- Superoxide anion

1O2 Singlet oxygen

•OH Hydroxyl radical

ROS Reactive oxygen species

shRNA Short hairpin RNA

SSB Single strand break

Sv Sievert

TFT Trifluorothymidine

TK Thymidine kinase

TK6 cells Human B lymphoblastoid cell line

Tr Transfected

TRITC Tetramethylrhodamine isothiocyanate

TXRND1 Thioredoxin reductase 1

UV Ultraviolet

UVA Ultraviolet A radiation, λ = 315-400 nm

UVB Ultraviolet B radiation, λ = 280-315 nm

UVC Ultraviolet C radiation, λ = 200-280 nm

WR Radiation weighting factor

6-4PPs Pyrimidine (6–4) pyrimidone photoproducts

7

Introduction

Radiation in human life

Radiation is a part of our everyday environment. All humans are inevitably exposed to some level

of background radiation that originates from natural and artificial sources. Natural sources

comprise cosmic rays (sun and outer space rays), decay of various radionuclides in the Earth´s

crust and radioactive isotopes in the human body such as 14C, 3H and primarily 40K [1]. Artificial

sources consist of medical diagnostic and therapeutic procedures, discharges of radioactive waste

from nuclear industries and fallout from nuclear weapons. The background level of radiation

varies in different parts of the world. For instance, there are areas in Brazil, China, India, and Iran

where the estimated annual effective dose to the population is several fold higher than the global

average level (2.4 mSv/year) [2]. Inhabitants of high background radiation areas do not show

signs of detrimental health effects compared to individuals living in the rest of the world, but this

is not surprising in view of their relative small number [3]. However, a better understanding of

the health effects of chronic background radiation is a challenge for radiation research.

Ionizing radiation

Ionizing radiation (IR) is able to ionize molecules in exposed matter and induce chemical

alterations. There are a few different radiation qualities that carry enough energy to cause

ionization, such as high energy photons (γ- and X-rays) or particles (electrons, protons, α-

particles, neutrons, and heavy charged ions) [4]. IR can be characterized based on its linear

energy transfer (LET) to matter, often expressed as keV/µm. Photons that sparsely deposit their

energy to the penetrated material are classified as low-LET and particles with dense energy

depositions are considered as high-LET type of radiation. The unit of absorbed energy of IR is

the Gy (1 Gy = 1 J/kg). Due to the differences in energy distribution for low- compared to high-

LET types of radiation, the consequences and biological effects for important target molecules

such as DNA per unit dose will be different [5]. This is considered in radiation protection

practices by introducing the equivalent dose Sievert (Sv) that will allow for risk estimates where

the exposure conditions consist of several different radiation qualities. The equivalent dose Sv is

8

thus derived from the absorbed dose (Gy) by multiplying it with the radiation weighting factor

(WR); [Sv = WR x Gy] where WR are estimates of the biological effectiveness (cancer) of the

different radiation qualities, ranging from 1-20. Thus, 1 Sv of α-particles and γ-rays are

considered to produce the same risk (cancer) [4], although the absorbed dose of alpha particles is

20 times lower than that of γ-rays.

High dose versus low dose

According to ICRP (International Commission on Radiological Protection) recommendations,

publication 103, doses below 100 mSv are considered as low and doses above are considered as

moderate or high [6]. Dose rates below 0.1 mGy/min are considered to be low [7].

Biological effects of radiation, deterministic and stochastic effects, are dose dependent.

Deterministic effects which are lethal to cells and lead to functional loss in tissues or organs are

only induced at high doses. The severity of deterministic effects increases with dose and below a

certain threshold there is no such effect. The threshold dose varies for different organs, depending

on the organ sensitivity. According to ICRP recommendations, publication 103 and a review

published in 2008, 100 mSv is the threshold dose below which no deterministic effects are

induced [6, 8]. At low doses, stochastic effects such as mutations, cancer or hereditary disorders

are of main concern, although they will also be induced at high doses. Due to the lack of reliable

epidemiological data that permit estimates of the level of risk for low doses, the shape of the dose

response curve for stochastic effects at low doses is not known and may be described based on

several models. At present, ICRP accepts the linear non threshold (LNT) model and assumes it to

be the most appropriate way of extrapolating risk below 100 mSv. The model predicts linearity of

radiation-related cancer risk with dose down to very low doses, assuming that any dose has the

potential to induce cancer [9]. The LNT model is mainly based on epidemiological data obtained

from the life span studies of the atomic bomb survivors (figure 1).

9

Figure 1: Schematic representation of different models for extrapolation of cancer risk following

exposure to low dose radiation. Curve a, linear extrapolation (LNT); curve b and c, nonlinear

dose response models that would result in overestimation and underestimation, respectively, of

risk if the LNT model is correct; curve d, threshold model; curve e, hormesis model (adapted

from [9]).

Dose rate effect

As mentioned earlier, most data on stochastic effects of radiation are from atomic bomb survivors

exposed to high dose rates while not enough data are available for health effects of protracted

exposures over long periods of time. Therefore, the study of dose rate effects, especially at low

dose rates, remains a high priority in radiation research. It is accepted that high dose rates induce

more malignancies and are more cytotoxic than low dose rates [10]. At low dose rates more time

is available for repair before the next hit is happening in juxtaposition of the first one, thus the

probability of interaction and formation of complex damage is lower. In other words, when the

dose rate is low the transient accumulation of damage will also be low and, subsequently, the

efficiency or fidelity of repair is high [11].

10

For the purpose of radiation protection, a dose and dose-rate effectiveness factor (DDREF) is

defined as the factor by which the risk of causing stochastic effects induced by high acute doses

of low-LET IR should be reduced when the same dose is delivered at low dose rates.

At present, ICRP publication 103 recommends a DDREF of 2, meaning that the slope of the

dose-response at low doses or low dose-rates is half the slope compared to that for high doses and

high dose-rates [8, 12]. However, the BEIR (biological effects of ionizing radiation) VII

Committee of the National Academy of Sciences (USA) has come up with an even more

conservative policy and concludes that the best estimate of the DDREF is 1.5 [13]. In support for

the BEIR VII policy, recent studies of human populations provide evidence that cancer risks at

low dose rates (occupational exposures) are not lower than at high dose rates (atomic bomb

survivors) [14, 15]. More support comes from the studies for the risk of developing leukemia in

humans, as it is not reduced by exposure to protracted radiation [16]. On the other hand, a report

by Preston [15] suggests that the health effects of radiation may possibly be significantly reduced

after very low dose rate exposures compared to what is currently estimated. Therefore an accurate

estimation of DDREF for humans remains an open question.

For high-LET radiation, due to the lack of a dose rate effect [17], the DDREF is 1.

Action of ionizing radiation

The interaction of radiation with biological molecules occurs through direct and indirect means

(figure 2). Direct action involves direct ionization or excitation of the target molecule, initiating a

chain of reactions that leads to biological effects. This is the dominant mechanism of action for

high-LET radiation. For instance, direct and dense ionization from α-particles (high-LET) along a

path induces a high level of clustered DNA damage (at least two lesions within less than 10 base

pairs) [18]. Indirect action involves the interaction of radiation with other molecules (e.g. water)

to produce free radicals that ultimately interact with the target molecule and induce damage.

Interaction of ionizing radiation with water molecules gives rise to formation of reactive oxygen

species (ROS) and, consequently, to oxidative stress. Low-LET radiation interacts predominantly

(approximately 70%) through indirect action [4].

11

Figure 2: A representation of direct and indirect action of ionizing radiation (modified

after [4]).

Non-ionizing radiation

Non-ionizing radiation refers to photons in the electromagnetic spectrum with wave lengths

longer than 200 nm. The energy of these photons is not sufficient to ionize molecules along their

path. Ultraviolet (UV), visible light, infra-red, etc. comprise different types of non-ionizing

radiation among which UV has the shortest wave lengths (200 to 400 nm) and has been studied in

this thesis. The main natural source of UV radiation is sunlight. However, the health effects of

exposure to artificial sources such as solariums are becoming in concern. UV radiation is

classified as UVA (320–400 nm), UVB (280–320 nm) and UVC (200–280 nm). The Earth’s

atmosphere filters UVC (completely) and UVB (mostly), therefore UVA is the main (95%) type

of UV radiation that reaches the Earth. Annual UV exposure to sunlight, in different parts of the

world, causes a total dose of 27 J/cm2 (United Kingdom) to 156 J/cm2 (Australia) to the human

skin [19]. The ability of UV radiation to penetrate the skin is proportional to the wavelength of

the rays, thus UVA can penetrate deep into the dermis of the skin whilst UVB is absorbed

superficially in the epidermis. Skin aging, development of skin cancers and immunosuppression

in humans are possible adverse effects of UVA exposure [20]. UVB is known to be a potent skin

cancer risk factor, responsible for erythema (sunburn) and immunosuppression. However, solar

UVB is essential for the synthesis of vitamin D, which may potentially reduce the risk of colon

[21], prostate and ovarian cancers [22, 23].

12

Action of UV radiation

UV radiation can induce damage either directly (UVB and UVC) through the excitation of DNA

bases or indirectly (mainly UVA) through the excitation of endogenous photosensitizers and

further induction of ROS (figure 3), which leads to increased levels of oxidative stress. During

indirect actions, excited photosensitizers such as riboflavin and NADH−/NADPH transfer energy

to substrates as DNA without intermediates (type I) or via singlet oxygen (type II) [24].

Figure 3. Mechanisms of UV radiation action for the induction of DNA damage (modified after

[24, 25]).

Oxidative stress

Oxidative stress refers to an imbalance between the formation of reactive species and antioxidant

capacity of the cell. This imbalance may result from an increased induction of reactive species or

diminished levels of antioxidants. Reactive species are free radicals and their derivatives that can

be induced endogenously as a result of natural metabolism, or exogenously as an outcome of

radiation or a particular chemical exposure. Oxygen and nitrogen radicals and their derivatives

are the major types of these reactive species. In this thesis, reactive oxygen species (ROS) are

discussed. ROS include superoxide radical anion (O2•-), hydroxyl radical (•OH), hydrogen

peroxide (H2O2) and singlet oxygen (1O2), among which •OH is the most reactive. •OH can react

with all molecules in a close proximity [26]. Singlet oxygen, preferentially, modifies guanine

13

[27] while superoxide has too low of a reactivity to induce such damage at all [28]. The

predominant action of γ-radiation is via the •OH radical. In contrast, UVA mainly operates via

singlet oxygen [29].

The natural formation of ROS, in an aerobic organism, occurs in the mitochondrial respiratory

chain where O2 is reduced to H2O by the transfer of four electrons and two protons. In this

process, possible leakage of single electrons (1-2%) may lead to a partial reduction of O2 to O2•-.

Formation of O2•- could lead to the formation of other types of ROS, such as •OH (figure 4).

Besides the mitochondrial electron transport chain, some other endogenous sources such as

oxidase enzymes (NADPH in phagocytes and xanthine oxidases) and redox cycling can also

induce O2•-. It is suggested that accumulation of unfolded proteins in the endoplasmic reticulum may

lead to ROS production [30]. Also, dietary mineral deficiencies, such as deficiencies in Zn2+,

Mg2+, Fe2+, and Cu2+ that are components of several antioxidant enzymes, can cause oxidative

stress [31-34].

It is estimated that about 1010 molecules of O2•- are produced in each human cell every day [35,

36]. This amount of endogenous ROS may, on average, induce about 106 DNA damage events

per cell per day [37]. The number of DNA double strand breaks (DSBs) induced by endogenous

ROS is approximately 103 times higher than that of radiogenic DSBs from background irradiation

[37, 38]. The number of ROS induced by 1Gy of γ-radiation is approximately 150 000 per cell

[39]. The magnitude of UVA-induced ROS per kJ/m2, measured indirectly as a yield of damage

per kJ/m2, is estimated to be less than what 1 Gy of γ-radiation induces [40].

Figure 4: Schematic representation of endogenous ROS formation (modified after [35, 41]).

14

Excessive levels of ROS, and consequently the state of oxidative stress in many cells, have been

correlated with aging, neurodegenerative diseases, carcinogenesis, and many other disorders [42-

45]. Apart from deleterious effects, ROS could help cells by taking part in the enhancement of

signal transduction, sensing of oxygen tension and immunological responses to environmental

pathogens [45]. Moreover, elevated ROS concentrations activate antioxidant genes such as

manganese superoxide dismutase (MnSOD) in order to maintain the redox homeostasis in many

cells [45].

Oxidative stress biomarkers

Due to the short half-life of ROS, a direct and precise method of measuring the level of oxidative

stress is not available today. However, indirect approaches, often referred to as fingerprinting

methods, have been applied as useful alternatives. Fingerprinting methods measure the specific

end products that result from the interaction of ROS with biomolecules, such as DNA, proteins

and lipids. The detectable end products are known as biomarkers of oxidative stress and some

examples are listed below [46-48].

8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG): biomarker for DNA base oxidation

protein carbonyl groups: biomarker for protein oxidation

malondialdehyde: biomarker for lipid peroxidation

Among these, oxidative DNA base biomarkers are of particular biological interest given that

DNA modifications can be genotoxic and also be transmitted over generations, which may result

in hereditary disorders. Guanine bases are found to be easily oxidized [49] due to their high redox

potential [50]. It is suggested that 8-oxo-dG is not metabolized in humans and its amount in urine

is unaffected by diet [51]. Therefore, 8-oxo-dG and 8-oxo-G have been used as sensitive markers

for oxidative stress in the nucleotide pool [52] and in the DNA, respectively.

15

DNA damage and repair

Radiation induces a wide variety of DNA damage. For instance, 1 Gy of γ-radiation causes

approximately 20-40 double strand breaks (DSBs), 1000 single strand breaks (SSBs), 1000

oxidative base damages, and 0-3 chromosomal aberrations [5, 53] among which DSBs are the

most dangerous type of DNA damage. As a consequence of a DSB, two broken ends of a

chromosome may rejoin wrongly and generate chromosomal aberrations (CA). These

chromosome rearrangements may occur within a chromosome (intra-CA) such as deletions, rings

and inversions or between two or more chromosomes (inter-CA) such as translocations and

dicentrics (figure 5) [54]. Formation of dicentrics and rings are lethal to cells. Therefore, these

types of aberrations are considered as unstable aberrations and will probably be lost from a

proliferating cell population. On the other hand, symmetric translocations and small deletions that

persist during cell proliferation are considered as stable aberrations [4]. DSBs are repaired by two

main pathways; homologous recombination (HR) and non-homologous end-joining (NHEJ). HR

provides a high-fidelity repair mechanism that takes place in late S–G2 phase while NHEJ is an

error prone but fast repair mechanism that functions throughout the whole cell cycle [55].

UV radiation can produce DNA photoproducts and/or reactive oxygen species and induce

different types of DNA damage. The types of DNA damage induced by UVA radiation include

oxidative DNA damage [56], SSBs, abasic sites, and cyclobutyl pyrimidine dimers (CPDs) [20].

UVB radiation, through direct absorption by DNA, mainly gives rise to the formation of CPDs

and pyrimidine (6–4) pyrimidone photoproducts (6-4PPs) [57, 58] and to a lesser extent oxidative

damage [59]. Nucleotide excision repair (NER) repairs both CPDs and (6-4PPs) [60].

16

Figure 5: Examples of chromosomal aberrations where the breaks and re-joins affect both sister-

chromatids (adapted from [61]).

Oxidative DNA damage and SSBs are repaired through the base excision repair (BER) pathway,

as described below.

Base excision repair (BER)

BER is the major repair pathway in mammalian cells that deals with oxidative DNA damage and

SSBs. This repair pathway is able to ensure the fidelity of base pairing via two general

mechanisms; short-patch and long-patch repair. The short-patch pathway results in the repair of a

single nucleotide while the long-patch leads to repair of at least two nucleotides. The core BER

pathway includes five enzymatic steps that remove damaged bases. In the first step, a DNA

glycosylase identifies and removes the damaged base, forming an apurinic or apyrimidinic site

(AP site). In the next step, a DNA AP endonuclease or a DNA AP lyase catalyzes the cleavage of

the DNA backbone. The endonucleases activity creates a single strand break which is filled in

(with a new nucleotide) by a DNA polymerase. DNA polymerase carries out two distinct

enzymatic activities in BER, which include DNA polymerase activity to fill in the gap, and 5´-

deoxyribophosphatase activity to cleave the 5´-phosphate forming an appropriate substrate for

efficient ligation. Ultimately, a DNA ligase restores the formation of phosphodiester bonds and

completes the repair [62]. The main BER proteins particularly involved in repair of 8-oxo-dG are

human MutY homolog (hMYH) and 8-oxoguanine DNA N-glycosylase 1 (hOGG1).

17

MYH is an adenine-specific glycosylase that removes post-replicative mispaired adenines such as

A/8-oxo-G, A/G and A/C, although the enzymatic activity on A/C mismatches is weak [63, 64].

The hMYH gene is located on chromosome 1 and contains 16 exons [65]. The gene products

contain nuclear and mitochondrial signals [66]. The activity of the hMYH protein is cell cycle

dependent. It has been shown that the maximum level of hMYH expression is in the S phase [67].

The lack of hMYH activity leads to G:C to T:A transversions (figure 6) [68] which has been

found to be implicated in the inherited predisposition to colorectal tumors [69]. A tumor

formation suppressor activity is attributed to MYH due to its function in mutation prevention [70]

and programmed cell death under oxidative stress conditions [71]. Recently, a functional p53-

binding site has been discovered in the human MYH gene, proposing that MYH is

transcriptionally regulated by p53 and that the involvement of MYH in programmed cell death

under oxidative stress is mediated by p53 [72].

OGG1 is a DNA glycosylase that recognizes and excises 8-oxoG when it is paired with C, G, or

T but not with A [73]. Two forms of the nuclear and mitochondrial human OGG1 protein are

encoded by the hOGG1 gene which is located on chromosome 3 [74]. hOGG1 prevents G:C to

T:A transversions through the correction of 8-oxoG:C mispairs. There is evidence suggesting that

single nucleotide polymorphism in the hOGG1 gene has been a risk factor for breast cancer [75].

Nucleotide pool sanitization and the role of MTH1

Recently it has become clear that the nucleotide pool is an important target for ROS induced

deoxyribonucleoside triphosphate (dNTP) modification [76, 77]. Modified dNTPs, e.g., 8-oxo-

dGTP, can be incorporated into the DNA during replication and give rise to mutations. The

sanitization enzyme hMTH1 (human Mut T homolog 1) prevents the incorporation of 8-oxo-

dGTP into DNA in mammals, figure 6. hMTH1 also known as hNUDT1 is an 18 kDa protein

encoded by the hMTH1 gene and located on chromosome 7p22 [78]. The hMTH1 gene produces

seven types of mRNAs, such as types 1, 2A, 2B, 3A, 3B, 4A, and 4B by alternative splicing [79].

The hMTH1 protein, which is mainly localized in the cytoplasm, is able to hydrolyze 8-oxo-

dGTP to 8-oxo-dGMP (as well as 2-hydroxy-dATP to 2-hydroxy-dAMP), inhibiting 8-oxo-dGTP

incorporation from the nucleotide pool into DNA [80]. The 8-oxo-dGMP is further

dephosphorylated to 8-oxo-dG by the action of 8-oxo-dGMPase and then excreted to the cell

18

exterior. Moreover, as mentioned earlier, excreted 8-oxo-dG into the extracellular milieu (in

urine, blood serum, cell culture medium) may be considered as a marker for oxidative stress.

Numerous evidences demonstrate that eliminating modified dNTPs from the nucleotide pool is

important for maintaining genomic integrity. As an example, the frequency of A:T to C:G

transversion has been found to be more predominant in bacteria deficient in Mut T than in wild

type [81]. The signaling processes that activates/regulate the expression of MTH1 are still

unclear.

Recently, the implication of MTH1 in tumor development as well as MTH1 suppression for

killing tumor cells have come into the focus for cancer biology research. For instance in mouse

studies, an increased number of tumors have been found in the lungs, liver, and stomach of

MTH1-deficient animals, as compared to wild-types [82]. In human studies, overexpression of

hMTH1 has been observed in brain [83] and lung [84] cancers. The role of hMTH1 in facilitating

RAS oncogene-induced non-small cell lung carcinoma has been explained as the ability of

hMTH1 to minimize the tumor-suppressive effects of ROS without entirely eliminating it [85]. In

gastric cancer patients, polymorphic variation of hMTH1 has more frequently been observed than

in healthy individuals and 20% of patients carried mutations in the p53 gene [86].

In contrast to normal cells, tumor cells undergo a high proliferative state and an active

metabolism possibly causing an increased level of oxidative stress. Hence, overexpression of

hMTH1 may be interpreted as a possible defensive mechanism for the survival of cancer cells.

Some recent studies have suggested that inhibition of hMTH1 could be lethal for cancer cells [87,

88]. As this thesis, paper I and II, indicates that hMTH1 cooperates with other proteins, namely

hMYH, in preventing oxidative damage, the hypothesis that suppression of MTH1 alone could

specifically kill cancer cells needs to be further investigated.

19

Figure 6: Mutagenesis caused by 8-oxoguanine and mammalian defense systems, modified after

[89].

Most of these types of DNA damage, if not repaired, may lead to genomic instability which refers

to an increased rate of acquisition of alterations within the genome. These alterations involve a

wide variety of biological end points including chromosomal aberrations, gene mutations and

micronuclei formation [90].

Adaptive response

A phenomenon in which pre-exposure to a low adapting dose of radiation (or any other mutagen)

enhances cellular abilities to cope with the adverse effects of a subsequent challenging dose is

known as adaptive response [91, 92]. Exposure to a low adapting dose could hypothetically

decrease the risk for detrimental health effects of radiation by two principal types of mechanisms

that are described below. One is to increase repair capacity or other cellular defense systems that

could prevent and repair DNA damage resulting in cell survival and proper cellular functions.

The other type is to reduce genomic instability by eliminating damaged cells through induction of

apoptosis, differentiation and immune responses [38, 93, 94]. Adaptive response may develop

within a few hours after radiation exposure and may last for several weeks to months depending

on cell type or tissue [95, 96]. An improved understanding of the underlying mechanisms of

20

adaptive response could shed light on the shape of the dose response curve for radiation-induced

cancer risk at low doses. This phenomenon is also of relevance for the clinical applications of

radiation in medicine. However, due to the variability of response depending on the different

cellular model systems, radiation conditions and endpoints, the phenomenon of adaptive response

is not universally accepted.

Bystander effect

Bystander effect is described as manifestation of radiation-induced cellular effects in non-

targeted cells neighboring targeted cells [97, 98]. These effects may result from signals generated

by irradiated cells secreted to non-irradiated cells or from molecules transported through cell-to-

cell gap junctions. Bystander effects could be beneficial (e.g. adaptive response) or detrimental

(e.g. transformation) to non-targeted cells. Although the mechanisms responsible for bystander

effect is not clearly understood and the effect is not universally accepted, generally, it appears to

be a low dose phenomenon [99]. Thus, a comprehensive understanding of radiation-induced

bystander effects could possibly have an impact on the cancer risk estimations at low doses.

Radiation and epigenetics

The classic definition of epigenetics describes stable heritable changes in gene expression

without alterations in the DNA sequence [100]. These changes may be induced through a number

of processes such as DNA methylation, histone modifications and non-coding RNA. Radiation

epigenetics is an emerging area of research that has been studied since 1980s and it may bring

insights into cellular responses to radiation. Epigenetic modifications have been found in various

human diseases including cancer and indeed studies of these changes have influenced the

understanding of radiation induced-carcinogenesis. DNA methylation is the most extensively

studied mechanism of epigenetics. A global DNA hypomethylation has mostly been observed

post-irradiation [101, 102] although hypermethylation in promoter regions of tumor-suppressor

genes has also been found to play a role in radiation-induced carcinogenesis. In addition, changes

in chromatin conformation, leading to a more open structure, and altered non-coding RNA

expression have been observed in response to radiation exposure [103]. However, epigenetic

changes can be highly dependent on tissue, sex, dose, and radiation quality [104, 105]. Although

the epigenetic effects of radiation and the underlying mechanisms need further investigations,

they may be considered as changes that have an impact on the late effects of radiation that drive

21

or protect normal cells to/from cancer. The epigenetic alterations that protect cells from cancer

may be induced by low dose and dose rate low-LET radiation through e.g. activation of apoptosis

or tumor suppressor genes [106].

Aim of the thesis

The main aim of this thesis is to understand the mechanisms behind genotoxic effects of

radiation-induced oxidative stress and induction of adaptive response that could be used to better

understand the shape of the dose response curve for risk estimates at low doses and low dose

rates of γ-radiation. The hypothesis behind the study is that exposure to γ- (at low dose rates) or

UVA-radiation increases formation of endogenous free radicals in the cells, which may lead to

oxidation of dNTPs and the subsequent induction of mutations and cancer. Thus, investigating

the role of proteins engaged in repair of oxidative damage in vitro could possibly shed light on

cancer induction associated with an exposure scenario.

We established cells with normal and low capacity to handle oxidative stress by down-regulating

(shRNA transfection method) the expression levels of MTH1 and/or MYH proteins and exposed

them to γ- or UVA-radiation. The impact of γ-radiation at low dose rates on the induction of

chromosomal aberrations (paper I) and mutation at the TK locus (paper I and II) were

investigated in the transfected and non-transfected cells. The influence of acute exposure to UVA

radiation on the mutation and 8-oxo-dG induction were studied in paper IV. The adaptive

response induced by low dose rates of γ-radiation was studied in paper III.

Methodology

Cell types

TK6 is a human B lymphoblastoid cell line isolated from the spleen of a 5-year-old boy with

known hereditary spherocytosis [107]. In humans, TK6 cells are heterozygous at the thymidine

kinase (TK) locus [108] which is mapped on chromosome 17 [109]. TK+/- heterozygotes are

suitable for mutation analysis. The function of P53 in TK6 cells is reported as normal [110].

22

Based on our results observed in paper I, there is a stable translocation between one of the

chromosomes 14 and an unpainted fragment. TK6 cells were cultured in RPMI-1640 medium

supplemented with 10% defined bovine calf serum, 1% Pest and 10 mM HEPES at 37 oC and 5%

CO2. The cell density was kept below 25 x 104/ml during the experiments.

The MCF-10A cell line is derived from human fibrocystic mammary epithelial tissue and does

not exhibit a normal karyotype [111]. A balanced translocation t (3;9) has been presented in these

cells. The cell culture medium, DMEM/F12 Ham, was supplemented with 10% horse serum, 1%

Pest, 10 µg/ml insulin, 20 ng/ml epidermal growth factor (EGF), 0.5 μg/ml hydrocortisone and

0.1 µg/ml cholera toxin. The cells were grown at 37 oC and 5% CO2. Experiments were

performed with 70% confluent cells (5 x 105 cells in 25 cm2 flasks flasks). 100% confluent cells

were sub-cultured after 5 days. Cells were detached from the flasks by 0.05% trypsin in EDTA

and washed with HBSS without calcium and magnesium.

Gene silencing

A stable silencing of the genes of interest was accomplished using short hairpin RNA (shRNA)

according to a standard protocol provided by Sigma-Aldrich. A lentiviral vector was used as a

tool to deliver shRNA into the cells. In order to increase the transfection efficiency,

hexadimethrine bromide was added to the cell culture medium. The shRNA was mixed with 3 x

104 TK6 cells in transfection medium, and after 20 hours puromycin was added to select the

transfected cells. After 5 days, the selected transfected cells were cultured in medium containing

low melting agarose gel and kept in a cell culture incubator for colony formation. Twenty

transfected colonies were picked up and expanded. In order to determine the expression levels of

transfected proteins, 1 x 105 cells from each colony were processed for western blot analysis. The

colonies that expressed the lowest level of transfected proteins were chosen for this study. The

transfection efficiency was also examined by using shRNA-producing GFP.

23

Irradiation

Exposure to γ-radiation was carried out acutely or chronically. For chronic exposure of cells (1.4,

5.0, 15.0, or 30.0 mGy/h), two different cell culture incubators equipped with 137Cs sources

(CRPR, Stockholm University) were used. The dose rates in one incubator were 5 to 30 mGy/h,

(figure 7A), and in the other incubator 1.4 mGy/h, (figure 7B). For acute exposure, a 137Cs source

(Scanditronix, Uppsala, Sweden) with the dose rate of 24 Gy/h was used at room temperature,

(figure 7C). The non-exposed cells were incubated in a separate incubator and received a

background dose rate of 0.0005 mGy/h. During chronic radiation exposure, TK6 cells were sub-

cultured every second day, and MCF10-A cells every 5 days.

UVA exposure was performed using an Osram Ultramed device at 122 W/m2 irradiance

described in paper IV. Briefly, TK6 cells were cultured in RPMI-1640 medium without phenol

red supplemented with 10% defined bovine calf serum, 1% Pest and 10 mM HEPES at 37 oC and

5% CO2 prior to the experiments. In order to irradiate approximately a monolayer of the cells, 0.5

×106 cells per 0.5 ml were placed on an 8.5 cm2 petri dish. Cells were irradiated on ice in petri

dishes without lids.

24

Figure 7: γ-radiation exposure

facilities. Panel A and B show the

chronic exposure incubators equipped

with 137Cs source 74 GBq (1993) and 137Cs source 370 GBq (2007),

respectively. Panel C shows the acute

exposure 137Cs source 33.3 TBq

(1985), (Scanditronix).

25

Clonogenic survival

Clonogenic survival of the acutely exposed cells to γ- or UVA-radiation was assessed by the

colony formation assay. For TK6 cells, clonogenic survival was performed immediately after

radiation exposure by seeding different numbers (50 to 800) of cells into 6 well plates containing

low melting agarose gel prepared in RPMI medium. The plates were cooled down at 4 °C for 20

minutes in order to solidify the gel, followed by 10-14 days incubation period for colony

formation. The clonogenic survival of MCF-10A cells was assessed after seeding a defined

number of cells (20-100) into 6 well plates containing culture medium. After 11 days of

incubation, cells were stained with methylene blue and visible colonies were counted manually.

Mutation analysis

Mutation analysis was assessed as the frequency of mutants at TK or HPRT locus in TK6 and

MCF-10A cells, respectively.

Mutants at the TK locus were selected using trifluorothymidine (TFT), a thymidine analogue

[112]. Following treatments, TK6 cells were cultured at 37 oC and 5% CO2 for 10 days in order to

allow mutants to express the mutated TK. During this time, cells were sub-cultured every second

day. After that, cells were seeded into 6 well plates containing low melting agarose gel mixed

with 2x concentrated RPMI medium and 5 μg/ml TFT. Cells resistant to TFT formed visible

colonies after a period of 10-14 days incubation at 37 oC and 5% CO2.

MCF-10A mutants at HPRT locus were selected using 6-thioguanine. Following treatments cells

were cultured at 37 oC and 5% CO2 for 11 days in order to allow the mutants to express the

mutated HPRT protein. Following the incubation time, cells were seeded into petri dishes

containing the culture medium (DMEM/F12 Ham) and 5 µg/ml 6-thioguanine. The cells were

incubated for 11 days to form colonies. Visible colonies were stained with methylene blue and

counted manually.

Mutant frequency (MF) at the TK or HPRT locus was calculated using the following formula: MF

= [(M/N) / CE] where M is the number of mutants, N is the number of total seeded cells in the

26

selection medium and CE is the clonogenic efficiency, without 6-thioguane or TFT treatment.

The mutant frequency was expressed as mutants per 105 surviving cells.

Chromosomal aberrations

Chromosomal aberrations were analyzed in cells at metaphase with fluorescence in situ

hybridization (FISH) chromosome painting technique. Treatment with colcemid trapped cells in

metaphase. Chromosomal aberrations were identified in three chromosomes with different sizes

(2, 8 and 14) using specific FISH probes in MTH1-transfected and wild type cells following γ-

radiation exposure. Hybridization was carried out according to the protocol from the

manufacturer with some modifications (details are explained in paper I). Around 1000

metaphases were scored for each treatment group. Images were captured by a Cool Cube 1 CCD

camera coupled to a fluorescence microscope that was equipped with filters for DAPI, FITC and

TRITC. Aberrations were classified as dicentrics (2A, one- or two-way), translocations (2B, one-

and two-way) rings (centric and acentric) and acentric fragments. Dicentrics and translocations

included exchanges between the three painted chromosomes and, for 2A exchanges, between the

homologous chromosomes. The scoring of primary breaks was achieved by transforming all

aberrations to the simple form, by estimating the number of primary breaks necessary to create

the observed exchange aberration.

Determination of 8-oxo-dG and dG

The measurements of intra and extracellular levels of 8-oxo-dG, as a marker for oxidative stress,

was carried out according to a modified ELISA protocol developed at the Stockholm University

[113] for detection of 8-oxo-dG in the medium, blood serum and cytoplasm. Briefly, 1 ml

medium was filtered through a C18 bond elute column. The elute containing 8-oxo-dG was

freeze dried, re-solved in PBS and filtered again in order to remove compounds that interact with

the 8-oxo-dG primary antibody. The purified samples were resolved in PBS, mixed with 8-oxo-

dG antibody and added to a 96-well plate pre-coated with 8-oxo-dG. After incubation, the wells

were washes 3 times and treated with a secondary antibody. Thereafter, the plate was washed 3

times and staining solution was applied followed by 15 min incubation at room temperature.

Following incubation, phosphoric acid was added to each well and the intensity of the color was

measured at 450 nm using an ELISA plate reader. The dG quantification was performed by

27

reversed phase HPLC with UV-detection, the details of the technique is explained by Osterman-

Golkar et al. [114].

Real-time PCR and PCR

The gene expression was investigated at mRNA level. Firstly, RNA was isolated from the cells

according to the standard protocol by Sigma-Aldrich, and further examined for the quality and

quantity. Secondly, the isolated RNA was transcribed to cDNA (Thermo Scientific) using PCR.

The kinetics of the cDNA amplification in the presence of the EvaGreen dye was monitored

using a LightCycler® real-time PCR System provided by Roche. The experiments were

performed according to the protocols supplied by manufacturers.

Results and discussion

Paper I

Mutations and chromosomal aberrations in hMTH1-transfected and non-transfected TK6 cells

after exposure to low dose rates of gamma radiation

In this paper, the dose rate effects of γ- radiation and the role of hMTH1 protein against

radiation-induced oxidative stress were investigated in human lymphoblastoid TK6 cells. With

the tools of gene silencing, short hairpin RNA (shRNA), we stably transfected cells against

hMTH1. Transfection efficiency was validated with Western blot analysis, showing that the

expression level of hMTH1 in transfected cells was down regulated to 12%. The cells were

exposed to 0.5 and 1.0 Gy cumulative doses of γ-radiation at dose rates of 1.4, 5.0, 15.0, and 30.0

mGy/h as well as 24 Gy/h. After exposure, growth rate, clonogenic survival, mutant frequency,

and chromosomal aberrations were investigated in both wild type and hMTH1-transfected cells.

Growth rate was measured during chronic exposure to 0.0, 1.4, 5.0 or 15.0 mGy/h γ- radiation for

23 days, in both cell types. The results demonstrated that increasing dose rates, > 1.4 mGy/h,

reduced the growth rate in both wild type and hMTH1-transfected cells. Notably, the growth rate

in hMTH1- transfected cells was slightly, non-significantly, lower than that in non-transfected

cells. This pattern was observed at all dose rates. Clonogenic survival assay in cells exposed to

28

acute doses of γ-radiation resulted in a non-significantly lower survival for transfected cells as

compared to wild type cells. The values for LD50 (the dose that results in 50% survival) were

0.33 Gy and 0.36 Gy for transfected and wild type cells, respectively. The frequency of mutants

were studied after chronic and acute exposures to γ-radiation at the accumulated doses of 0.5 and

1.0 Gy in both cell types. The results showed an overall dose dependent increase in mutation

induction while no significant dose rate effect. These patterns were seen in both transfected and

wild type cells. Comparing mutant frequencies between transfected and wild type cells, no

significant difference was observed. Moreover, the data indicated that radiation increased the

level of mutation significantly, almost 2- to 4-fold above the background level in both cell types.

Radiation-induced chromosomal aberrations were analyzed in chromosomes 2, 8 and 14 in both

transfected and wild type cells. The accumulated dose was 1 Gy administered at 1.4 to 30.0

mGy/h. A stable translocation was seen in both cell lines between chromosome 14 and an

unpainted fragment (not counted as an aberration). In control cells, no aberrations were detected

beside this stable translocation. Overall, when comparing exposed cells, no increase in stable

aberrations was seen with the dose rate. On the other hand, an inversed dose rate effect was

observed particularly for transfected cells. For unstable-type aberrations and primary breaks, a

clear increase was observed with increasing dose rates in both types of cells. A significant

difference between the two cell lines was only seen for primary breaks in the cells exposed at

15.0 mGy/h. However, this result must be interpreted with caution in view of the fact that a single

experiment was carried out.

The same response to γ-radiation-induced oxidative stress in hMTH1-transfected and wild type

cells could be explained in various ways; a) due to low yields of the oxidized dGTP under our

exposure conditions; b) due to up regulation of other pathways responsible for handling oxidative

stress. We may also speculate that the remaining expression of hMTH1 after transfection (12%)

has been sufficient to hydrolyze 8-oxo-dGTP in the nucleotide pool. The absence of a dose rate

effect in our study is in agreement with other´s data for TK6 cells [115, 116].

29

Main findings in paper I:

A dose rate effect was absent for mutations and stable-type aberrations in TK6 cells.

Silencing the expression level of hMTH1 down to 12% had no influence on the cellular

response to γ-radiation-induced oxidative stress, with respect to survival, growth,

mutations, and chromosomal aberrations.

Paper II

Cooperation of MTH1 and MYH proteins in response to oxidative stress induced by chronic

gamma radiation

This study aimed at investigating the role of MYH and MTH1 proteins in response to γ-radiation-

induced oxidative stress. As in paper I, we found that down regulation of MTH1 does not

influence the sensitivity of TK6 cells to γ-radiation, thus it was interesting to investigate how

cells compensate this deficiency in the expression of MTH1. Therefore, in this study we focused

on the role of MYH and its cooperation with MTH1 in repair of oxidative damage. Using

shRNA, we established two cell lines differing in expression level of MYH and MTH1 proteins.

MYH expression was down regulated to 2.6% in one cell line and the levels of MTH1 and MYH

in the other cell line were simultaneously reduced to 14% and 22%, respectively. After the

exposure of cells to chronic and acute γ-radiation, the growth rate, clonogenic survival level and

mutant frequency were analyzed. The accumulated doses of 0.5 and 1.0 Gy were delivered at 1.4,

5.0, 15.0, and 30.0 mGy/h as well as an acute dose rate (24 Gy/h).

The clonogenic survival results did not show any significant differences among the three cell

types. The LD50 values for each cell line were as follows: wild type 0.61 Gy, MYH-Transfected

30

0.61 Gy and MYH- and MTH1-transfected 0.51 Gy. However, the levels of cell survival and

growth (significant reductions at 5 and 15 mGy/h) were lower in cells lacking the complete

expression of both MTH1 and MYH in comparison to that in MYH deficient or wild type cells.

In contrast, MYH deficient cells did not show any higher sensitivity to radiation at the level of

survival and growth rate in comparison to wild type cells. The frequency of mutants in MYH and

MTH1 deficient cells was higher (in general) than that in MYH deficient or wild type cells.

However, for wild type and MYH deficient cells a similar level of mutant frequency was found

following acute and chronic exposures. Comparing MTH1 deficient cells (paper I) with cells

lacking the expression of both MTH1 and MYH, we found that later cells grow slower (at 5 and

15 mGy/h exposures), survive less (non-significantly) and have higher mutant frequency than

MTH1 deficient cells when exposed to γ-radiation.

These observations may primarily suggest that oxidative stress induced by chronic and acute γ-

radiation is significantly more mutagenic in MYH and MTH1 deficient cells than in cells lacking

the expression of either MTH1 or MYH or in wild type cells. The interpretation of the results

could be as follows; once deficient cells in MYH and MTH1 are exposed to an elevated level of

oxidative stress due to radiation exposure and at the same time have elevated levels of modified

dNTPs in the cytoplasm (due to low levels of MTH1), they will be extremely sensitive in terms

of mutations. As we compare the results in paper I and in the present study, it appears that in the

stress condition lack of one protein (either MYH or MTH1) in TK6 cells could be compensated

by the action of the other in terms of cell growth and mutations. This may lead us to conclude

that MYH and MTH1 back each other up in response to radiation-induced oxidative damage.

However, due to the limitations of the transfection assay, the expression levels of MYH and

MTH1 proteins were not equally down regulated. Therefore, the proportional involvement of

each protein in prevention of mutations is not clear. Importantly, as mutations in MYH have been

related to development of colorectal cancer, our study could possibly be of help to better

understand the pathogenesis or prevention of this cancer.

31

Main findings in paper II:

MYH and MTH1 proteins cooperatively protect TK6 cells against radiation-induced

mutations.

We suggest that the activity/expression level of MTH1 should be considered in parallel

with MYH activity/expression for studies related to MYH-associated diseases.

Mutation induction by γ- radiation in TK6 cells is not dose rate dependent.

Paper III

Adaptive response induced by different dose rates of γ-radiation in MCF-10A cells

Radiation-induced adaptive response is one of the controversial aspects of radiation protection

research. Despite decades of investigation, there is still uncertainty about the radiation condition

and mechanisms under which adaptive response could be induced. Therefore, in this study, we

aimed at investigating dose rates that could possibly induce adaptive response. MCF-10A cells

were pre-exposed to acute (24 Gy/h) or chronic (1.4 or 4.1 mGy/h) γ-radiation to give an

accumulated dose of 50 mGy. Following 2 hours of incubation time, the cells were exposed to

doses between 0 to 5 Gy challenging doses and were analyzed for clonogenic survival and mutant

frequency.

The clonogenic survival results showed that acute or chronic pre-exposures to 50 mGy γ-

radiation do not induce any adaptive response in MCF-10A cells that could be detected after

subsequent exposures to (1-5 Gy) challenging doses. In contrast to survival level, the frequency

of mutants was significantly reduced when MCF-10A cells were exposed to 50 mGy adapting

dose at 1.4 mGy/h and challenged by 1 Gy, as compared to cells exposed to only 1 Gy. In a

32

separate experiment, MCF-10A cells were exposed to 0.1 and 1.0 Gy γ- radiation administered

acutely (24 Gy/h) and chronically (1.4 or 4.1 mGy/h) for the investigation of dose rate effect at

the mutation level. The results showed no dose rate effect.

Induction of adaptive response, mutation frequency, by lowering the dose rate of the adapting

dose could be due to an enhanced repair capacity, antioxidant activity or even change in

chromatin conformation that may be induced during protracted radiation exposure. The induction

of some signaling pathways, possibly due to the increased levels of ROS induced by low dose

rate exposure, may trigger activation of DNA repair genes that leads to repair of DNA damages

induced by a high challenging dose. The variation of adaptive response in our results depending

on endpoints, absence at survival and presence at mutation level, is in agreement with the data

found in other studies. This variability may have different explanations e.g. the radiation-induced

lethal lesions and/or their repair are possibly different from those leading to mutations. Another

explanation for this discrepancy assumes that mutation induction and cell death are not

necessarily related. Cells may preferentially repair the lethal lesions rather than mutations.

However, due to the variability of adaptive response depending on endpoint, cellular systems and

radiation conditions the mechanisms behind it remain elusive. The interesting outcome of this

study is the absence of a dose rate effect at the levels of clonogenic survival and mutation which

confirms our previous finding in paper I and II. Nevertheless, adaptive response at the level of

mutation seems to be dose rate dependent; the lower the dose rates the lower the frequency of

mutants.

Main findings in paper III:

Exposure to low dose γ-radiation, 50 mGy, at a dose rate as low as 1.4 mGy/h can induce

an adaptive response in MCF-10A cells at the level of mutation.

Low dose rate γ-radiation does not induce adaptive response at the survival level in MCF-

10A cells.

Overall, a dose rate effect is absent at the level of mutation in MCF-10A cells.

33

Paper IV

Reduction of 8-oxo-dGTP in the nucleotide pool by hMTH1 leads to reduction in mutations in

the human lymphoblastoid cell line TK6 exposed to UVA

In this study, the impact of UVA-induced oxidative stress and the role of the hMTH1 protein

were investigated. TK6 cells were transfected using shRNA to stably down regulate the

expression level of hMTH1. The transfection efficiency was validated by Western blot analysis.

The expression level of hMTH1 in transfected cells was down regulated to 12% of that in wild

type cells. Cells were exposed to different doses of UVA and analyzed for clonogenic survival,

mutant frequency, extracellular and intracellular levels of 8-oxo-dG, and the concentration of dG

in the nucleotide pool.

The results from the clonogenic survival assays did not indicate a significant difference between

the two cell types. The LD50 values were 34 and 39 kJ/m² for transfected and wild type cells,

respectively. The mutant analysis data demonstrated a significantly increased mutant frequency

in transfected and wild type cells after 29 kJ/m² UVA exposure in comparison to non-exposed

cells. Interestingly, the UVA-induced increase of mutant frequency in transfected cells was

significantly higher than that in wild type cells. However, at 18 kJ/m², the mutant frequency in

transfected cells was not significantly different compared to wild type cells. Regarding the level

of intracellular dG, our data indicated that there was no difference between transfected and wild

type cells in non-exposed conditions. Interestingly, the 8-oxo-dG content in the nucleotide pool

increased significantly with increasing dose in the transfected cells. On the contrary, in wild type

cells the cytoplasmic level of 8-oxo-dG decreased significantly at 29 kJ/m² in comparison to that

in transfected cells.

These observations indicate that transfected cells, due to the lack of hMTH1 have a reduced

capacity to dephosphorylate 8-oxo-dGTP, causing elevated levels of it in the nucleotide pool

34

whereas wild type cells with the help of hMTH1 activity are able to dephosphorylate 8-oxo-

dGTP and excrete it outside the cell (the observed reduction of 8-oxo-dG).

In contrast to the results in this study (UVA exposure), the data in paper I (γ-radiation exposure)

did not result in any significantly different mutant frequency between hMTH1-transfected and

wild type cells. We may explain this discrepancy induced by different radiation qualities by

comparing the doses of UVA and γ-radiation used in these experiments. In UVA exposures, the

administered doses (18 and 29 kJ/m²) were approximately 50% and 80% of the LD50 dose and in

γ-radiation exposures the doses (0.5 and 1.0 Gy) were 150% and 200% of the LD50 dose,

respectively. This may suggest that the role of hMTH1 in handling oxidative stress in the

nucleotide pool is more pronounced at a certain level of free radicals and above that level, cells

may cope with stress conditions through other mechanisms. According to the previous findings in

our group [76] the expression of hMTH1 in response to free radicals induced by γ-radiation

saturates around the doses of 30-50 mGy. In other words, at 0.5 or 1.0 Gy of γ-radiation where

we do not observe any protective role for hMTH1 at mutation level, cells may have sensed some

signals due to the high level of free radicals and have triggered activation of alternative repair

proteins in the nucleotide pool or in the nucleus.

Main findings in paper IV:

The hMTH1 protein protects TK6 cells against mutations induced by UVA radiation.

The nucleotide pool is a significant target for the mutagenic effect of UVA.

35

Concluding remarks

Oxidative stress, due to the involvement in mutagenicity and cancer, is a risk factor for human

health. As it has also been shown, other kinds of illnesses such as neurodegenerative diseases,

ageing and diabetes may arise from oxidative stress [117, 118]. Therefore, studies on factors

inducing stress and understanding the mechanisms that protect humans from deleterious effects

of ROS need to be taken into consideration. UVA and γ-radiation are potent inducers of oxidative

stress. Formation of 8-oxo-dG as a consequence of the action of ROS on DNA bases is a

potential risk for mutation induction; mainly G:C to T:A and A:T to C:G transversions in human

cells. The nucleotide pool sanitization and the base excision repair enzymes, MTH1 and MYH

respectively, are two of the key proteins that can prevent mutations induced by excess levels of

ROS.

According to the data presented in paper IV, we suggest a protective role of MTH1 in

mutagenicity of UVA and propose that the nucleotide pool is a significant target for ROS as

elevated levels of 8-oxo-dGTP were observed in MTH1-downregulated cells after exposure to

UVA. The cooperative action of MTH1 and MYH in preventing mutations induced by low and

high dose rates of γ-radiation observed in paper I and II indicates that these two proteins back

each other up against deleterious effects of oxidative stress. This finding may be useful for

understanding the biology of cancer, especially colorectal cancer, which is suggested to arise

from mutations in the MYH gene.

The dose rate dependence for adaptive response that was found in paper III against mutagenicity

of γ-radiation in MCF-10A cells, while no such effect was found at the survival level, will need

further studies to be explained but may have the potential to identify relevant endpoints for an

adaptive response in relation to risk. Indeed, due to the variability of response depending on

endpoints, further investigations are necessary to establish a universal condition under which

adaptive response could be induced.

36

The lack of a dose rate effect for mutagenicity of γ-radiation that is repeatedly observed in this

thesis (paper I, II and III) may be an important point for radiation protection research. Our

finding suggests a dose and dose rate effectiveness factor (DDREF) of around 1 for stochastic

effects of γ-radiation.

Ongoing and future studies

Gene expression profiling of MTH1, OGG1 and antioxidant enzymes HMOX1 and TXNRD1

after exposure to low dose rates of γ-radiation

To understand the cellular responses that deal with different levels of oxidative stress induced by

low dose rates of γ-radiation, the expression level of some repair (MTH1 and OGG1) and

antioxidant (HMOX1 and TXRND1) genes are being monitored at the mRNA level using real-

time PCR. TK6 cells have been exposed to 1.4, 5.0 or 15.0 mGy/h γ-radiation and sampled after

3, 24 hours and 1 week. The analysis of the real-time PCR data is underway.

Epigenetic changes induced by chronic γ-radiation in human fibroblasts

As growing evidences indicate that epigenetic modifications are among the delayed effects of

ionizing radiation (IR), it may be suggested that IR-induced genome instability and

transgenerational effects may be epigenetically mediated. Understanding the epigenetic

mechanisms related to low dose and low dose rate radiation may also provide valuable

information with significant implications in radiation protection and cancer prevention. To

investigate the possible epigenetic modifications induced by γ-radiation, human fibroblasts have

been exposed to 1.0 Gy at 4.1 mGy/h. The cells have been sub-cultured and repeatedly collected

from 3 hours up to 28 days post-irradiation. The global expression levels of DNA

methyltransferases: DNMT1, DNMT3a and DNMT3b are planned to be measured with real-time

PCR tools.

For future studies, characterization of the mutation types at the thymidine kinase locus induced

by low dose rate γ-radiation in hMYH and/or hMTH1 down regulated cells using sequencing

37

techniques may shed more light on the mechanisms behind chronic IR mutagenesis. To further

understand the relation between oxidative stress and carcinogenesis especially colorectal cancer,

a combination of in vitro and in vivo studies that focus on the role of MTH1 and MYH in stress

condition could be beneficial. Investigating the status of MYH and MTH1 as well as antioxidant

genes in colorectal cancer patients may help finding solutions for cancer prevention in susceptible

individuals. Moreover, studies related to dietary antioxidants could be a complementary

investigation for cancer prevention.

Acknowledgments

This thesis was funded by the Swedish Radiation Safety Authority (SSM) and the FP7 project

EpiRadBio. I am grateful for their financial support.

I would like to thank my supervisor Siamak Haghdoost for giving me the opportunity to start my

PhD in his group. Siamak, I am very thankful for your guidance, patience and help in the lab, for

your trust in my ideas and for your effort in educating me. I enjoyed doing research under your

supervision. Being involved in the world of the nucleotide pool is all because of you.

I am very grateful to Andrzej Wojcik, my co-supervisor. Andrzej, fruitful discussions with you

have taught me a lot about radiobiology. Your knowledge, wise behaviour and friendly character

has made you the perfect supervisor.

I would like to especially thank Mats Harms-Ringdahl. Mats, thank you for your excellent

advices, help and discussions. Thank you for the time you spent in reading and commenting my

writings. The attention you pay to all of us, the warm and friendly group you have created, your

funny jokes, and the positive energy that you spread throughout the group is brilliant and

unbelievable.

Siv Osterman-Golkar, thank you for all the help in proofreading my writings. Without your smart

and precise comments, I would not be able to find my mistakes.

38

Asal Fotouhi, studying and working with you made my PhD time very exciting and fun. Teaching

duties without your help in translating and teamwork would be impossible. Thank you for your

help and kindness in the lab and all the fun we had together.

Traimate Sangsuwan, thank you for your indescribable patience in helping me whenever I needed

(to find cells, software problems and in the lab). Without your Western blot analysis my projects

would not have proceeded.

Sara Skiöld, thank you for your help and patience in teaching me 2D-Gels. I will try to save the

late nights and time you spent on the project. It was very fun to share the S.A.T.S. office and

coffee clubs with a super nice person like you. I miss working with you.

Ainars Bajinskis, thank you for your help in the lab, finding funds, booking trips, sharing the

S.A.T.S. office and nice coffee clubs. Especially enjoyed access to your “Ainarspedia” facilitated

searching.

Eliana Beltran, thank you for all the PCR and real time-PCR help. Late working and non-working

hours with you were so fun.

Marta, thank you for all the chromosomal aberration scorings. It was a pleasure to be a colleague

and friend with you.

Marina Ilic, thank you for reading my thesis and being such fantastic friend and colleague.

Alice Sollazzo, Elina Staff, Karl Brehwens, Lei Cheng, and Ramesh Yentrapalli thank you for the

good time we had together in the lab and also apart from the lab.

Sara Eriksson, thanks for your help in qPCR and the PhD dissertation to-do list. I hope we see

each other more often in the neighborhood.

Daniel Vare, thank you for your help in scintillation.

Harald Eriksson, coffee clubs without your company would not be fun.

39

Never ending thanks to my parents for the love, support, strength, and encouragement they gave

me throughout my life. You were and will always be the first and the most important people in

my life.

Countless thanks to my brothers, Arash and Ashkan, for their love and support. Having you two

means having everything.

To my friends, thank you for all the times you stood by me and gave me energy to live happier.

To my grandparents, I always thank you. Rest in peace. Grandfather, you knew what I did not

know!

References 1. Asimov, I., The radioactivity of the human body. Journal of Chemical Education, 1955. 32(2): p.

84-5.

2. UNSCEAR, Sources and effects of ionizing radiation. United Nations Scientific Committee on the

Effects of Atomic Radiation (UNSCEAR), 2008. I(Annex B).

3. Hendry, J.H., et al., Human exposure to high natural background radiation: what can it teach us

about radiation risks? J Radiol Prot, 2009. 29(2A): p. A29-42.

4. Hall, E.J., Radiobiology for radiobiologist. 7th edn.

5. Goodhead, D.T., Initial events in the cellular effects of ionizing radiations: clustered damage in

DNA. Int J Radiat Biol, 1994. 65(1): p. 7-17.

6. ICRP, The 2007 Recommendations of the International Commission on Radiological Protection.

ICRP Publication 103. Ann. ICRP, 2007. 37: p. 2-4.

7. Muirhead, C.R., Cox, R., Stather, J.W., MacGibbon, B.H., Edwards, A.A., & Haylock, R.G.E.,

Estimates of late radiation risks to the UK population. Documents of the NRPB, 1993. 4(4): p.

15-157.

8. Wrixon, A.D., New ICRP recommendations. J Radiol Prot, 2008. 28(2): p. 161-8.

9. David J. Brennera, b., et al., Cancer risks attributable to low doses of ionizing radiation:

Assessing what we really know. PNAS, 2003. 100: p. 13761-6.

10. Elkind, M.M. and H. Sutton, X-ray damage and recovery in mammalian cells in culture. Nature,

1959. 184: p. 1293-5.

40

11. Dikomey, E. and I. Brammer, Relationship between cellular radiosensitivity and non-repaired

double-strand breaks studied for different growth states, dose rates and plating conditions in a

normal human fibroblast line. Int J Radiat Biol, 2000. 76(6): p. 773-81.

12. Wakeford, R. and E.J. Tawn, The meaning of low dose and low dose-rate. J Radiol Prot, 2010.

30(1): p. 1-3.

13. National Academy of Sciences, Health Risks From Exposure to Low Levels of Ionizing Radiation,

BEIR VII, Phase 2. National Academy Press, Washington DC 2006.

14. Jacob, P., et al., Is cancer risk of radiation workers larger than expected? Occupational and

environmental medicine, 2009. 66(12): p. 789-796.

15. Preston, D.L. From epidemiology to risk factors. in Proceeding of the Third MELODI Workshop.

2011.

16. Daniels, R. and M. Schubauer-Berigan, A meta-analysis of leukaemia risk from protracted

exposure to low-dose gamma radiation. Occupational and environmental medicine, 2010.

17. Giles, N.H., Comparative Studies of the Cytogenetical Effects of Neutrons and X-Rays. Genetics,

1943. 28(5): p. 398-418.

18. Goodhead, D.T., J. Thacker, and R. Cox, Weiss Lecture. Effects of radiations of different qualities

on cells: molecular mechanisms of damage and repair. Int J Radiat Biol, 1993. 63(5): p. 543-56.

19. Gies, P., et al., Global Solar UV Index: Australian Measurements, Forecasts and Comparison

with the UK¶. Photochem Photobiol, 2004. 79(1): p. 32-39.

20. Freeman, S.E., et al., Production of pyrimidine dimers in DNA of human skin exposed in situ to

UVA radiation. J Invest Dermatol, 1987. 88(4): p. 430-3.

21. Garland, C.F. and F.C. Garland, Do sunlight and vitamin D reduce the likelihood of colon cancer?

Int J Epidemiol, 1980. 9(3): p. 227-231.

22. Schwartz, G. and B. Hulka, Is vitamin D deficiency a risk factor for prostate cancer?(Hypothesis).

Anticancer Res, 1989. 10(5A): p. 1307-1311.

23. LEFKOWITZ, E.S. and C.F. Garland, Sunlight, vitamin D, and ovarian cancer mortality rates in

US women. Int J Epidemiol, 1994. 23(6): p. 1133-1136.

24. Foote, C.S., Definition of type I and type II photosensitized oxidation. Photochem Photobiol,

1991. 54(5): p. 659-659.

25. Kielbassa, C., L. Roza, and B. Epe, Wavelength dependence of oxidative DNA damage induced by

UV and visible light. Carcinogenesis, 1997. 18(4): p. 811-816.

26. Halliwell, B., Free radicals and other reactive species in disease. 2005: Wiley Online Library.

41

27. Epe, B., Genotoxicity of singlet oxygen. Chemico-Biological Interactions, 1991. 80(3): p. 239-260.

28. Fischer-Nielsen, A., I.B. Jeding, and S. Loft, Radiation-induced formation of 8-hydroxy-2'-

deoxyguanosine and its prevention by scavengers. Carcinogenesis, 1994. 15(8): p. 1609-1612.

29. Cadet, J., et al., Oxidative damage to DNA: formation, measurement, and biological significance,

in Reviews of Physiology Biochemistry and Pharmacology, Volume 131. 1997, Springer. p. 1-87.

30. Malhotra, J.D. and R.J. Kaufman. The endoplasmic reticulum and the unfolded protein response.

in Seminars in cell & developmental biology. 2007. Elsevier.

31. Rayssiguier, Y., et al., Magnesium and ageing. I. Experimental data: importance of oxidative

damage. Magnesium research: official organ of the International Society for the Development of

Research on Magnesium, 1993. 6(4): p. 369-378.

32. Bettger, W.J., et al., Interaction of zinc and vitamin E in the chick. Exp Biol Med (Maywood),

1980. 163(3): p. 432-436.

33. Young, I.S., et al., Antioxidant status and lipid peroxidation in hereditary haemochromatosis.

Free Radical Biology and Medicine, 1994. 16(3): p. 393-397.

34. Sukalski, K.A., T.P. LaBerge, and W.T. Johnson, In vivo oxidative modification of erythrocyte

membrane proteins in copper deficiency. Free Radical Biology and Medicine, 1997. 22(5): p. 835-

842.

35. Frei, B., Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med,

1994. 97(3A): p. 5S-13S; discussion 22S-28S.

36. Ames, B.N., M.K. Shigenaga, and T.M. Hagen, Oxidants, antioxidants, and the degenerative

diseases of aging. Proceedings of the National Academy of Sciences, 1993. 90(17): p. 7915-7922.

37. Pollycove, M. and L.E. Feinendegen, Radiation-induced versus endogenous DNA damage:

possible effect of inducible protective responses in mitigating endogenous damage. Human &

experimental toxicology, 2003. 22(6): p. 290-306.

38. Feinendegen, L., Evidence for beneficial low level radiation effects and radiation hormesis. 2014.

39. Feinendegen, L., Reactive oxygen species in cell responses to toxic agents. Human &

experimental toxicology, 2002. 21(2): p. 85-90.

40. Pouget, J.-P., et al., DNA damage induced in cells by γ and UVA radiation as measured by

HPLC/GC-MS and HPLC-EC and comet assay. Chem Res Toxicol, 2000. 13(7): p. 541-549.

41. Jomova, K. and M. Valko, Advances in metal-induced oxidative stress and human disease.

Toxicology, 2011. 283(2): p. 65-87.

42. Good, P.F., et al., Evidence of neuronal oxidative damage in Alzheimer's disease. The American

journal of pathology, 1996. 149(1): p. 21.

42

43. Troncoso, J.C., et al., In vitro polymerization of oxidized tau into filaments. Brain Res, 1993.

613(2): p. 313-316.

44. Dreher, D. and A. Junod, Role of oxygen free radicals in cancer development. Eur J Cancer, 1996.

32(1): p. 30-38.

45. Dröge, W., Free radicals in the physiological control of cell function. Physiol Rev, 2002. 82(1): p.

47-95.

46. Helbock, H.J., K.B. Beckman, and B.N. Ames, 8-Hydroxydeoxyguanosine and 8-hydroxyguanine

as biomarkers of oxidative DNA damage. Methods Enzymol, 1999. 300: p. 156-166.

47. Dalle-Donne, I., et al., Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chimica

Acta, 2003. 329(1): p. 23-38.

48. Nielsen, F., et al., Plasma malondialdehyde as biomarker for oxidative stress: reference interval

and effects of life-style factors. Clin Chem, 1997. 43(7): p. 1209-1214.

49. Kasai, H. and S. Nishimura, Hydroxylation of deoxyguanosine at the C-8 position by ascorbic

acid and other reducing agents. Nucleic Acids Res, 1984. 12(4): p. 2137-2145.

50. Jovanovic, S.V. and M.G. Simic, One-electron redox potentials of purines and pyrimidines. The

Journal of Physical Chemistry, 1986. 90(5): p. 974-978.

51. Halliwell, B., Effect of diet on cancer development: Is oxidative DNA damage a biomarker? Free

Radical Biology and Medicine, 2002. 32(10): p. 968-974.

52. Haghdoost S, C.S., Näslund I, Skog S, Harms-Ringdahl M., extracellular 8-oxo-dg as a sensitive

parameter for oxidative stress in vivo and in vitro. Free Radical Research, 2005. 39: p. 153-62.

53. Pouget, J.P. and S.J. Mather, General aspects of the cellular response to low- and high-LET

radiation. Eur J Nucl Med, 2001. 28(4): p. 541-61.

54. Savage, J.R., An introduction to chromosomal aberrations. Atlas Genet Cytogenet Oncol

Haematol, 1999.

55. Mahaney, B.L., K. Meek, and S.P. Lees-Miller, Repair of ionizing radiation-induced DNA

double-strand breaks by non-homologous end-joining. Biochemical Journal, 2009. 417: p. 639-

650.

56. O'Donovan, P., et al., Azathioprine and UVA light generate mutagenic oxidative DNA damage.

Science, 2005. 309(5742): p. 1871-1874.

57. Sutherland, B.M., L.C. Harber, and I.E. Kochevar, Pyrimidine dimer formation and repair in

human skin. Cancer Res, 1980. 40(9): p. 3181-3185.

58. Setlow, R.B., The wavelengths in sunlight effective in producing skin cancer: a theoretical

analysis. Proceedings of the National Academy of Sciences, 1974. 71(9): p. 3363-3366.

43

59. Cadet, J., T. Douki, and J.L. Ravanat, Oxidatively generated damage to cellular DNA by UVB and

UVA radiation. Photochem Photobiol, 2014.

60. Iyama, T. and D.M. Wilson III, DNA repair mechanisms in dividing and non-dividing cells. DNA

Repair, 2013. 12(8): p. 620-636.

61. JRK, S., An Introduction to Chromosomal Aberrations. . March 1999.

62. Robertson, A.B., et al., DNA repair in mammalian cells: Base excision repair: the long and short

of it. Cell Mol Life Sci, 2009. 66(6): p. 981-93.

63. Tsai-Wu, J.-J., H.-F. Liu, and A.-L. Lu, Escherichia coli MutY protein has both N-glycosylase and

apurinic/apyrimidinic endonuclease activities on AC and AG mispairs. Proceedings of the

National Academy of Sciences, 1992. 89(18): p. 8779-8783.

64. Au, K.G., et al., Escherichia coli mutY gene encodes an adenine glycosylase active on GA

mispairs. Proceedings of the National Academy of Sciences, 1989. 86(22): p. 8877-8881.

65. Slupska, M.M., et al., Cloning and sequencing a human homolog (hMYH) of the Escherichia coli

mutY gene whose function is required for the repair of oxidative DNA damage. J Bacteriol, 1996.

178(13): p. 3885-3892.

66. Takao, M., et al., Differential subcellular localization of human MutY homolog (hMYH) and the

functional activity of adenine: 8-oxoguanine DNA glycosylase. Nucleic Acids Res, 1999. 27(18):

p. 3638-3644.

67. Boldogh, I., et al., hMYH cell cycle-dependent expression, subcellular localization and

association with replication foci: evidence suggesting replication-coupled repair of adenine:8-

oxoguanine mispairs. Nucleic Acids Res, 2001. 29(13): p. 2802-9.

68. Nghiem, Y., et al., The mutY gene: a mutator locus in Escherichia coli that generates GC----TA

transversions. Proceedings of the National Academy of Sciences, 1988. 85(8): p. 2709-2713.

69. Al-Tassan, N., et al., Inherited variants of MYH associated with somatic G: C→ T: A mutations in

colorectal tumors. Nature Genetics, 2002. 30(2): p. 227-232.

70. David, S.S., V.L. O'Shea, and S. Kundu, Base-excision repair of oxidative DNA damage. Nature,

2007. 447(7147): p. 941-950.

71. Oka, S. and Y. Nakabeppu, DNA glycosylase encoded by MUTYH functions as a molecular switch

for programmed cell death under oxidative stress to suppress tumorigenesis. Cancer Sci, 2011.

102(4): p. 677-682.

72. Oka, S., et al., MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-

dependent cell death. Oncogenesis, 2014. 3(10): p. e121.

73. Lu, A.-L., et al., Repair of oxidative DNA damage. Cell Biochem Biophys, 2001. 35(2): p. 141-

170.

44

74. Takao, M., et al., Mitochondrial targeting of human DNA glycosylases for repair of oxidative

DNA damage. Nucleic Acids Res, 1998. 26(12): p. 2917-2922.

75. Xie, H., et al., Genetic polymorphism in hOGG1 is associated with triple-negative breast cancer

risk in Chinese Han women. Breast, 2013.

76. Sangsuwan, T. and S. Haghdoost, The nucleotide pool, a target for low-dose gamma-ray-induced

oxidative stress. Radiat Res, 2008. 170(6): p. 776-83.

77. Fotouhi, A., et al., Reduction of 8-oxodGTP in the nucleotide pool by hMTH1 leads to reduction

in mutations in the human lymphoblastoid cell line TK6 exposed to UVA. Mutation

Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2011. 715(1): p. 13-18.

78. Furuichi, M., et al., Genomic Structure and Chromosome Location of the Human< i> mutT</i>

Homologue Gene< i> MTH1</i> Encoding 8-Oxo-dGTPase for Prevention of A: T to C: G

Transversion. Genomics, 1994. 24(3): p. 485-490.

79. Oda, H., et al., Multi-forms of human MTH1 polypeptides produced by alternative translation

initiation and single nucleotide polymorphism. Nucleic Acids Res, 1999. 27(22): p. 4335-4343.

80. Nakabeppu, Y., et al., Biological significance of the defense mechanisms against oxidative

damage in nucleic acids caused by reactive oxygen species: from mitochondria to nuclei. Annals

of the New York Academy of Sciences, 2004. 1011(1): p. 101-111.

81. Maki, H. and M. Sekiguchi, MutT protein specifically hydrolyses a potent mutagenic substrate for

DNA synthesis. Nature, 1992. 355(6357): p. 273-5.

82. Tsuzuki, T., et al., Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-

oxo-dGTPase. Proceedings of the National Academy of Sciences, 2001. 98(20): p. 11456-11461.

83. Iida, T., et al., Accumulation of 8-oxo-2′-deoxyguanosine and increased expression of hMTH1

protein in brain tumors. Neuro Oncol, 2001. 3(2): p. 73-81.

84. Kennedy, C.H., H.I. Pass, and J.B. Mitchell, Expression of human MutT homologue (hMTH1)

protein in primary non-small-cell lung carcinomas and histologically normal surrounding tissue.

Free Radical Biology and Medicine, 2003. 34(11): p. 1447-1457.

85. Patel, A., et al., MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant

pathways. Oncogene, 2014.

86. Kimura, Y., et al., A variant form of hMTH1, a human homologue of the E coli mutT gene,

correlates with somatic mutation in the p53 tumour suppressor gene in gastric cancer patients. J

Med Genet, 2004. 41(5): p. e57-e57.

87. Gad, H., et al., MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.

Nature, 2014. 508(7495): p. 215-221.

45

88. Huber, K.V., et al., Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy.

Nature, 2014.

89. Nakabeppu, Y., Cellular Levels of 8-Oxoguanine in either DNA or the Nucleotide Pool Play

Pivotal Roles in Carcinogenesis and Survival of Cancer Cells. International journal of molecular

sciences, 2014. 15(7): p. 12543-12557.

90. Morgan, W.F., et al., Genomic instability induced by ionizing radiation. Radiat Res, 1996. 146(3):

p. 247-58.

91. Tuschl, H., et al., Effects of Low-Dose Radiation on Repair Processes in Human-Lymphocytes.

RADIATION RESEARCH, 1980. 81(1): p. 1-9.

92. Olivieri, G., J. Bodycote, and S. Wolff, Adaptive response of human lymphocytes to low

concentrations of radioactive thymidine. Science, 1984. 223(4636): p. 594-597.

93. Potten, C.S., Extreme sensitivity of some intestinal crypt cells to X and γ irradiation. 1977.

94. Makinodan, T. and S.J. James, T cell potentiation by low dose ionizing radiation: possible

mechanisms. Health Phys, 1990. 59(1): p. 29-34.

95. Feinendegen, L., et al., Cellular mechanisms of protection and repair induced by radiation

exposure and their consequences for cell system responses. Stem cells (Dayton, Ohio), 1995. 13:

p. 7-20.

96. Yamaoka, K., R. Edamatsu, and A. Mori, Increased SOD activities and decreased lipid peroxide

levels induced by low dose X irradiation in rat organs. Free Radical Biology and Medicine, 1991.

11(3): p. 299-306.

97. Djordjevic, B., Bystander effects: A concept in need of clarification. BioEssays, 2000. 22(3): p.

286-290.

98. Kadhim, M., et al., Transmission of chromosomal instability after plutonium α-particle

irradiation. Nature, 1992. 355(6362): p. 738-740.

99. Dauer, L.T., et al., Review and evaluation of updated research on the health effects associated

with low-dose ionising radiation. Radiat Prot Dosimetry, 2010: p. ncq141.

100. Waddington, C.H., The epigenotype. Int J Epidemiol, 2012. 41(1): p. 10-13.

101. Tawa, R., et al., Effects of X-ray irradiation on genomic DNA methylation levels in mouse tissues.

J Radiat Res, 1998. 39(4): p. 271-278.

102. Pogribny, I., et al., Fractionated low-dose radiation exposure leads to accumulation of DNA

damage and profound alterations in DNA and histone methylation in the murine thymus.

Molecular cancer research, 2005. 3(10): p. 553-561.

46

103. Aypar, U., W.F. Morgan, and J.E. Baulch, Radiation-induced genomic instability: are epigenetic

mechanisms the missing link? Int J Radiat Biol, 2011. 87(2): p. 179-191.

104. Goetz, W., M.N. Morgan, and J.E. Baulch, The effect of radiation quality on genomic DNA

methylation profiles in irradiated human cell lines. Radiation research, 2011. 175(5): p. 575-587.

105. Pogribny, I., et al., Dose-dependence, sex-and tissue-specificity, and persistence of radiation-

induced genomic DNA methylation changes. Biochemical and biophysical research

communications, 2004. 320(4): p. 1253-1261.

106. Scott, B.R., et al., Radiation-stimulated epigenetic reprogramming of adaptive-response genes in

the lung: an evolutionary gift for mounting adaptive protection against lung cancer. Dose-

Response, 2009. 7(2): p. 104-131.

107. Levy, J.A., M. Virolainen, and V. Defendi, Human lymphoblastoid lines from lymph node and

spleen. Cancer, 1968. 22(3): p. 517-524.

108. Skopek, T.R., et al., Isolation of a human lymphoblastoid line heterozygous at the thymidine

kinase locus: possibility for a rapid human cell mutation assay. Biochem Biophys Res Commun,

1978. 84(2): p. 411-416.

109. MCDOUGALL, J.K., R. KUCHERLAPATI, and F.H. RUDDLE, Localization and induction of

the human thymidine kinase gene by adenovirus 12. Nature, 1973. 245(145): p. 172-175.

110. Xia, F., et al., Altered p53 status correlates with differences in sensitivity to radiation-induced

mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res, 1995. 55(1):

p. 12-15.

111. Soule, H.D., et al., Isolation and characterization of a spontaneously immortalized human breast

epithelial cell line, MCF-10. Cancer Res, 1990. 50(18): p. 6075-6086.

112. Heidelberger, C., D. Parsons, and D.C. Remy, Syntheses of 5-trifluoromethyluracil and 5-

trifluoromethyl-2'-deoxyuridine. J Am Chem Soc, 1962. 84(18): p. 3597-3598.

113. Haghdoost, S., et al., Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo

and in vitro. Free Radical Research, 2005. 39(2): p. 153-162.

114. Golkar, S.O., et al., Intracellular deoxyribonucleotide pool imbalance and DNA damage in cells

treated with hydroxyurea, an inhibitor of ribonucleotide reductase. Mutagenesis, 2013. 28(6): p.

653-660.

115. Grosovsky, A.J. and J.B. Little, Evidence for linear response for the induction of mutations in

human cells by x-ray exposures below 10 rads. Proceedings of the National Academy of Sciences,

1985. 82(7): p. 2092-2095.

116. König, F. and J. Kiefer, Lack of dose-rate effect for mutation induction by γ-rays in human TK6

cells. Int J Radiat Biol, 1988. 54(6): p. 891-897.

47

117. Lin, M.T. and M.F. Beal, Mitochondrial dysfunction and oxidative stress in neurodegenerative

diseases. Nature, 2006. 443(7113): p. 787-95.

118. Kono, K., et al., Anti-oxidative effect of vitamin D analog on incipient vascular lesion in non-

obese type 2 diabetic rats. Am J Nephrol, 2013. 37(2): p. 167-74.